Primary Care Clinics in Trezevant, TN Accepting Medicare
1 Primary Care Clinics found. Showing 1 - 1
 Family Medical Clinic Of Trezevant Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 45 Hurt St, Trezevant, TN 38258 Phone: 731-207-0323 Fax: 731-240-8065 |
News Archive
Experimental vaccine candidate can stimulate immune system activity to prevent HIV infection
New research led by scientists at The Scripps Research Institute (TSRI), International AIDS Vaccine Initiative (IAVI) and The Rockefeller University shows in mice that an experimental vaccine candidate designed at TSRI can stimulate the immune system activity necessary to stop HIV infection. The findings could provide key information for the development of an effective AIDS vaccine.
Bipolar disorder ‘frequent' in depressive borderline personality disorder
Study results indicate that bipolar disorder may occur in up to half of individuals with co-existing borderline personality disorder and depression.
Scientists, chefs explore ways to help people with neurologically-related taste impairments enjoy food again
Two women, seated at a table, told their stories in quiet tones. A group of chefs, some standing, others seated, leaned forward eagerly, clearly interested in what these two women had to say. They peppered the women with questions: did food taste better cold or hot? Was texture an issue? Did a glass of wine before dinner help or hurt the flavor experience? The women have taken chemotherapy for their cancer. One of them - Gina Mullin - will be taking chemotherapy every three weeks for the rest of her life. Both of them tell heartbreaking stories about a side effect of chemotherapy that gets swept under the rug: food tastes terrible.
Antigenics receives delisting notification letter from NASDAQ Stock Market
Antigenics Inc. announced that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC (the "Staff") on December 30, 2009 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.
YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering
YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.
› Verified 2 days ago